Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemia.
about
Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations.Recent advances in the management of pediatric acute lymphoblastic leukemia.Single-Gene Congenic Strain Reveals the Effect of Zbtb16 on Dexamethasone-Induced Insulin Resistance.Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia
P2860
Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemia.
@en
type
label
Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemia.
@en
prefLabel
Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemia.
@en
P2860
P356
P1476
Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemia.
@en
P2093
Julie A E Irving
P2860
P356
10.1111/BJH.13924
P407
P577
2016-01-05T00:00:00Z